Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
AEs were categorized according to their severity as follows: mild (no or transient symptoms, no interference with the subject's daily activities)
A: According to medical guidance: Life-Threatening Symptoms (Call 911): Difficulty breathing or severe shortness of breath Swelling of face, lips, tongue, or throat Severe allergic reaction (anaphylaxis) Chest pain Severe abdominal pain not resolving Loss of consciousness Serious but Non-Emergency Symptoms (Contact Provider Immediately/Same Day): Severe persistent nausea or vomiting (risk of dehydration) Inability to keep down fluids Severe abdominal pain Yellowing of skin or eyes (jaundice) Decreased or no urination Vision changes Lump or swelling in neck New or worsening depression or suicidal thoughts Moderate Bothersome Symptoms (Contact Provider Within 24-48 Hours): Nausea interfering with daily activities Persistent diarrhea or constipation Significant injection site reactions Concerning hair loss Other symptoms significantly impacting quality of life Response Options : Provider may adjust dose (slower escalation or temporary reduction) Provider may prescribe additional medications for symptom management Provider may recommend medication switch In rare cases, may recommend discontinuation Never hesitate to contact provider about concerning symptoms
Front Endocrinol 11:178 Marso SP, Daniels GH, Brown-Frandsen K, et al (2016) Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Litigation Information GLP-1 (formerly Ozempic) Lawsuit Overview Multiple lawsuits related to Ozempic (and other GLP-1 products) have been initiated by individuals who have experienced significant and damaging side effects
